Viewing StudyNCT01266967



Ignite Creation Date: 2024-05-05 @ 11:08 PM
Last Modification Date: 2024-10-26 @ 10:29 AM
Study NCT ID: NCT01266967
Status: COMPLETED
Last Update Posted: 2014-05-08
First Post: 2010-12-02

Brief Title: A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Melanoma and Brain Metastases
Keywords:
Name View
BRAF inhibitor View
GSK2118436 View
Metastatic melanoma to the brain View
Brain metastases View
Braf mutation View
Brain neoplasm View